Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Verdouw

Showing results (1-10 of 266) with videos related to

Pageof 27
Sort By:
Circulation|September 1, 1994
Exercise training confers anticipatory protection from sudden death during acute myocardial ischemiaP D Verdouw
British Journal of Pharmacology|February 1, 1985
5-Carboxamide tryptamine, a compound with high affinity for 5-hydroxytryptamine1 binding sites, dilates arterioles and constricts arteriovenous anastomosesP R Saxena, P D Verdouw
Circulation|April 16, 1998
Effects of ischemic preconditioningD J Duncker, P D Verdouw
Bibliotheca Cardiologica|January 1, 1971
Cardiovascular responses in pigs to body acceleration applied synchronously with the heartbeatA C Arntzenius, P D Verdouw
British Journal of Pharmacology|May 1, 1983
The effect of felodipine on ventricular fibrillation after coronary artery ligation in the anaesthetized pigP D Verdouw, B H Wolffenbuttel
British Journal of Pharmacology|August 1, 1984
Effects of methysergide and 5-hydroxytryptamine on carotid blood flow distribution in pigs: further evidence for the presence of atypical 5-HT receptorsP R Saxena, P D Verdouw
Scandinavian Cardiovascular Journal : SCJ|June 25, 2002
Inotropic therapy of heart failure. Editorial comments on: Vasodilation and mechanoenergetic inefficiency dominates the effect of the "Ca2+ sensitizer" MCI-154 in intact pigsD J Duncker, P D Verdouw
European Journal of Cardiology|December 1, 1975
Cardiovascular effects of aprindine, a new antiarrhythmic drugW J Remme, P D Verdouw
Cardiovascular Drugs and Therapy|April 8, 2000
Role of K+ATP channels in ischemic preconditioning and cardioprotectionD J Duncker, P D Verdouw
Arzneimittel-Forschung|January 1, 1984
Cardiovascular actions after intravenous and intracoronary administration of the slow channel blocker bepridilP D Verdouw, M G Scheffer
Pageof 27

Showing results (1-10 of 266) with videos related to

Sort By:
Pageof 27
Circulation|September 1, 1994
Exercise training confers anticipatory protection from sudden death during acute myocardial ischemiaP D Verdouw
British Journal of Pharmacology|February 1, 1985
5-Carboxamide tryptamine, a compound with high affinity for 5-hydroxytryptamine1 binding sites, dilates arterioles and constricts arteriovenous anastomosesP R Saxena, P D Verdouw
Circulation|April 16, 1998
Effects of ischemic preconditioningD J Duncker, P D Verdouw
Bibliotheca Cardiologica|January 1, 1971
Cardiovascular responses in pigs to body acceleration applied synchronously with the heartbeatA C Arntzenius, P D Verdouw
British Journal of Pharmacology|May 1, 1983
The effect of felodipine on ventricular fibrillation after coronary artery ligation in the anaesthetized pigP D Verdouw, B H Wolffenbuttel
British Journal of Pharmacology|August 1, 1984
Effects of methysergide and 5-hydroxytryptamine on carotid blood flow distribution in pigs: further evidence for the presence of atypical 5-HT receptorsP R Saxena, P D Verdouw
Scandinavian Cardiovascular Journal : SCJ|June 25, 2002
Inotropic therapy of heart failure. Editorial comments on: Vasodilation and mechanoenergetic inefficiency dominates the effect of the "Ca2+ sensitizer" MCI-154 in intact pigsD J Duncker, P D Verdouw
European Journal of Cardiology|December 1, 1975
Cardiovascular effects of aprindine, a new antiarrhythmic drugW J Remme, P D Verdouw
Cardiovascular Drugs and Therapy|April 8, 2000
Role of K+ATP channels in ischemic preconditioning and cardioprotectionD J Duncker, P D Verdouw
Arzneimittel-Forschung|January 1, 1984
Cardiovascular actions after intravenous and intracoronary administration of the slow channel blocker bepridilP D Verdouw, M G Scheffer
Pageof 27